Loading provider…
Loading provider…
Urology Physician in Dallas, TX
NPI: 1174577704Primary Practice Location
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
8200 Walnut Hill Ln, Dallas, TX
Primary Employer
Urology Clinics of North Texas, PLLC
urologyclinics.com
HQ Phone
Get M.D. James's Phone Numberphone_androidMobile
Get M.D. James's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
1970 - 2026

American Board of Urology
Urology
University of Texas Southwestern Medical Center
Residency • Urology
1974 - 1976
Residency • Urology
1971 - 1973
Internship • Internal Medicine
1970 - 1971
UT Southwestern Medical Center
utsouthwestern.edu
Medical School
Until 1970
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 81001Manual urinalysis test with examination using microscope | 251 | 317 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 248 | 278 |
| 3 | 84153PSA (prostate specific antigen) measurement | 221 | 242 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 161 | 182 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 157 | 222 |
Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors.
Authors: Cochran, J S, Walsh, P C, Porter, J C, Nicholson, T P, Peters, P C
Journal: Surg Forum
Clinical Urology: Letters to the EditorRE: DISAPPOINTING INITIAL RESULTS WITH TRANSURETHRAL ALPROSTADIL FOR ERECTILE DYSFUNCTION IN A UROLOGY PRACTICE SETTING
Authors: K. Subramonian, P.M.T. Weston
Publication Date: 1999-07
Authors: Paul Peters, Thomas Nicholson
Journal: J Urol
Lead Sponsor: BHR Pharma, LLC
Collaborators: Q2 Solutions, H2O Clinical LLC
Intervention / Treatment: DRUG: Placebo, DRUG: BHR-200 (0.36% transdermal 17β-estradiol gel)
Lead Sponsor: MDx Health
Lead Sponsor: Heat Biologics
Intervention / Treatment: BIOLOGICAL: Placebo, BIOLOGICAL: BCG, BIOLOGICAL: HS-410